Beta-cell therapy for daibetes : development of quality assured transport of human islets for transplantation at remote centres, investigation of augmentation of human islets ex vivo, and exploration of the potential for expansion and redifferentiation in vitro
Beta cell replacement is the only therapy currently able to restore insulin independence in C-peptide negative Type 1 diabetes. This can be achieved through either vascularised whole pancreas transplantation or isolated islet transplantation. Whole pancreas transplantation can deliver long-term norm...
Main Author: | |
---|---|
Published: |
University of Newcastle Upon Tyne
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.574732 |